Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

BACKGROUND: Gastric cancer (GC) is a heterogenous disease consisted of several subtypes with distinct molecular traits. The clinical implication of molecular classification has been limited especially in association with treatment efficacy of ramucirumab or various targeted agents. METHODS: We condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seung Tae, Sa, Jason K., Oh, Sung Yong, Kim, Kyung, Hong, Jung Yong, Kang, Won Ki, Kim, Kyoung-Mee, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836461/
https://www.ncbi.nlm.nih.gov/pubmed/33494793
http://dx.doi.org/10.1186/s13073-021-00826-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836461/
https://www.ncbi.nlm.nih.gov/pubmed/33494793
http://dx.doi.org/10.1186/s13073-021-00826-w

Ejemplares similares